Levodopa responsiveness of dysphagia in advanced Parkinson's disease and reliability testing of the FEES-Levodopa-test

被引:74
|
作者
Warnecke, Tobias [1 ]
Suttrup, Inga [1 ]
Schroeder, Jens B. [1 ]
Osada, Nani [2 ]
Oelenberg, Stephan [1 ]
Hamacher, Christina [1 ]
Suntrup, Sonja [1 ]
Dziewas, Rainer [1 ]
机构
[1] Univ Hosp Munster, Dept Neurol, Albert Schweitzer Campus 1, D-48149 Munster, Germany
[2] Univ Munster, Dept Med Informat, Domagkstr 9, D-48149 Munster, Germany
关键词
Parkinson's disease; Dysphagia; Swallowing; FEES; Levodopa responsiveness; DOPAMINERGIC STIMULATION; SWALLOWING ABNORMALITIES; AGREEMENT; DIAGNOSIS; THERAPY;
D O I
10.1016/j.parkreldis.2016.04.034
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: It is still controversially discussed whether central dopaminergic stimulation improves swallowing ability in Parkinson's disease (PD). We evaluated the effect of oral levodopa application on dysphagia in advanced PD patients with motor fluctuations. Methods: In 15 PD patients (mean age 71.93 +/- 8.29 years, mean disease duration 14.33 +/- 5.94 years) with oropharyngeal dysphagia and motor fluctuations endoscopic swallowing evaluation was performed in the off state and on state condition following a specifically developed protocol (FEES-levodopa-test). The respective dysphagia score covered three salient parameters, i.e. premature spillage, penetration/aspiration events and residues, each tested with liquid as well as semisolid and solid food consistencies. An improvement of >30% in this score indicated levodopa responsiveness of dysphagia. Measures were compared between the off-and on-state condition by using the Wilcoxon Test and marginal homogeneity test. Inter- and intrarater reliability was also investigated. Results: Severity of swallowing dysfunction in the off state varied widely. The lowest dysphagia score was 15 points (dysphagia without any aspiration risk). The highest dysphagia score was 84 points (dysphagia with aspiration of all consistencies). Seven patients showed a marked improvement of dysphagia in the on state condition. Eight PD patients did not respond. Inter- and intrarater reliability was excellent for all three subscales in the off state and on state conditions. Conclusions: A significant proportion of advanced PD patients with motor fluctuations and mild to moderate oropharyngeal dysphagia may demonstrate a clinically relevant improvement of swallowing after levodopa challenge. The FEES-levodopa-test is a reliable and sensitive tool to differentiate these responders from non-responders. (C) 2016 Elsevier Ltd. All rights reserved.
引用
收藏
页码:100 / 106
页数:7
相关论文
共 50 条
  • [21] Parkinson's disease - Levodopa complications
    King, DB
    CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1999, 26 : S13 - S20
  • [22] Prosody and levodopa in Parkinson's disease
    de Azevedo, Luciana Lemos
    da Conceicao Reis, Cesar Augusto
    de Souza, Irene Soares
    Costa Cardoso, Francisco Eduardo
    ARQUIVOS DE NEURO-PSIQUIATRIA, 2013, 71 (11) : 835 - 840
  • [23] Levodopa, ayurveda and Parkinson's disease
    Deleu, D
    Hanssens, Y
    Northway, MG
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2001, 184 (01) : 89 - 90
  • [24] Levodopa in the treatment of Parkinson's disease
    Fahn, S.
    JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT, 2006, (71): : 1 - 15
  • [25] Levodopa in the treatment of Parkinson's disease
    Koller, WC
    NEUROLOGY, 2000, 55 (11) : S2 - S7
  • [26] Levodopa and the progression of Parkinson's disease
    Fahn, S
    Shoulson, I
    Kieburtz, K
    Rudolph, A
    Lang, A
    Olanow, CW
    Tanner, C
    Marek, K
    NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (24): : 2498 - 2508
  • [27] Locus coeruleus degeneration associated with less levodopa responsiveness in Parkinson's disease
    Zhou, C.
    Zhang, B.
    Zhang, M.
    MOVEMENT DISORDERS, 2021, 36 : S392 - S393
  • [28] DUODENAL CARBIDOPA/LEVODOPA: AN OPPORTUNITY FOR ADVANCED PARKINSON'S DISEASE PATIENTS
    Gayoso Rey, Monica
    Lopez Diaz, Luis Manuel
    ATENCION FARMACEUTICA, 2013, 15 (05): : 362 - 364
  • [29] Riluzole for levodopa-induced dyskinesias in advanced Parkinson's disease
    Merims, D
    Ziv, I
    Djaldetti, R
    Melamed, E
    LANCET, 1999, 353 (9166): : 1764 - 1765
  • [30] Piribedil as an adjunct to levodopa in advanced Parkinson's disease: the Asian experience
    Evidente, VGH
    Esteban, RP
    Domingo, FM
    Carbajal, LO
    Parazo, MA
    PARKINSONISM & RELATED DISORDERS, 2003, 10 (02) : 117 - 121